CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

The rapid spread of animal diseases and pathogen evolution have long posed significant threats to the healthy development of ...

New research breaks down how scientists use CRISPR technology to lower cholesterol. The cholesterol-lowering effects could be permanent.

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery ...

GenEditBio Limited ("GenEditBio"), a Hong Kong -headquartered clinical-stage biotechnology company specializing in novel deliveries, including lipid nanoparticle (LNP)-based delivery systems, ...

KIT researchers succeeded for the first time in reducing the number of chromosomes in a plant using the CRISPR/Cas method – surprisingly without affecting its growth The CRISPR/Cas molecular scissors ...

The new knowledge could lead to the use by CBI of renewable microbes and plant cells from poplar trees and switchgrass (two non-edible plants that grow fast) for demonstrating the scaled-up industrial ...